Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8226362 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 8 Pages |
Abstract
GS and post-treatment PSA-DT are both statistically significant independent predictors of metastatic disease. Patients with a high GS and/or short PSA-DT have a higher likelihood of developing metastatic disease and should be considered for systemic therapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Kevin M.D., Ryan M.D., Nelson M.D., Richard G. M.D.,